New scan for detecting and staging certain cancers
Part of Cancer clinical trials.
This trial tests a new imaging agent (68Ga-FL-031) to see if it can help find and stage tumors in people with small cell lung cancer, breast cancer, nasopharyngeal cancer, or other cancers. The goal is to improve diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must have suspected or confirmed small cell lung cancer, breast cancer, nasopharyngeal cancer, or another type of tumor (with supporting test results like blood tests, ultrasounds, CT, or MRI)
- You must be in generally good health
- You must agree to follow the study procedures and allow your samples to be used for research
- You must be able to sign an informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent called FL-261 to help doctors see and stage cancers more clearly. If you have a known or suspected cancer like lung, colon, or head and neck cancer, this study may improve how your cancer is evaluated.
This study tests a new imaging agent called FL-091 to see if it helps doctors find and stage cancers like head and neck, colorectal, or pancreatic cancer. You’ll get a PET scan that may give clearer pictures of tumors.
This study tests a new PET scan tracer that aims to highlight cancer cells more clearly. If you join, you'll receive one injection of the tracer and then have a PET/CT scan to help your doctor see whether you have cancer or where it is.
This trial tests a special imaging technique that may help doctors see and stage solid tumors more precisely. It uses a targeted radioactive tracer to highlight cancer cells during PET and SPECT scans, which could help plan better treatment.
This trial tests a new imaging agent that helps find cancer cells that have come back. It is given as an injection and then a scan is done to see if it helps doctors locate the cancer.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
Hear when a new PET trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.